PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1877438
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1877438
Medical Imaging market size was valued at US$ 41,234.56 Million in 2024, expanding at a CAGR of 5.1% from 2025 to 2032.
Medical imaging comprises advanced modalities such as X-ray, MRI, CT, ultrasound, and nuclear imaging used to diagnose, monitor, and guide treatment by creating detailed anatomical and functional visuals. Rising global disease burden continues to expand imaging demand-the International Agency for Research on Cancer (IARC) reports 19.3 million new cancer cases in 2020, sharply increasing the need for early detection infrastructure. Major opportunities include AI-enabled image interpretation, remote diagnostics, portable and point-of-care imaging, and the replacement cycle driven by the shift toward high-resolution, low-radiation systems worldwide.
Medical Imaging Market- Market Dynamics
Rising global diagnostic imaging demand driven by increasing disease burden and expanding scan volumes to propel market demand
The growing prevalence of chronic diseases, aging populations, and rising clinical reliance on early diagnostic screening are major factors driving the global Medical Imaging market. According to the World Health Organization (2023), non-communicable diseases account for 74% of global deaths, significantly increasing demand for diagnostic modalities such as CT, MRI, ultrasound, and X-ray. Correspondingly, imaging procedure volumes continue to grow worldwide: OECD data shows CT exam rates rising from 133 to 153 exams per 1,000 population between 2015 and 2022, while MRI exams increased from 65 to 76 per 1,000 population during the same period. Emerging markets, including India, Brazil, and Southeast Asia, are also reporting double-digit annual scan volume growth due to expanding hospital infrastructure and government investments in diagnostic capacity. This rise in global imaging workload is accelerating the adoption of high-performance scanners, AI-enabled diagnostics, and advanced workflow solutions, strengthening market demand across modalities.
The Global Medical Imaging Market is segmented on the basis of Procedure, Modality, Technology, Patient, Propulsion, End User, and Region.
The market is divided into seven categories based on Procedure: X-ray, MRI, CT, Ultrasound, Mammography, Nuclear Imaging (SPECT/PET), and Molecular Imaging, along with other specialized procedures. X-ray imaging remains the most widely adopted modality due to its affordability, diagnostic versatility, and high procedure volumes. According to the WHO Global Health Observatory, X-ray accounts for over 60% of all imaging procedures worldwide, making it the backbone of diagnostic workflows in both developed and emerging healthcare systems. However, CT and MRI are witnessing stronger long-term growth. OECD data shows CT exam rates increasing from 133 to 153 exams per 1,000 population (2015-2022), fueled by expanded emergency care use and improved scanner availability. MRI volumes also rose from 65 to 76 exams per 1,000 population over the same period, driven by rising demand for neurological, musculoskeletal, and oncology diagnostics.
The market is divided into multiple clinical areas based on application, including General Imaging, Obstetrics, Thoracic Cardiology, Orthopaedics & Musculoskeletal, Pelvic & Abdominal, Neuro & Spine, Oncology, Fluoroscopy, Radiography, Gynaecology, Musculoskeletal, Urology, Dental, and others. Among these, the Oncology segment is expected to experience the highest growth, driven by rising global cancer incidence and increased adoption of PET/CT, MRI, and advanced CT imaging. According to the International Agency for Research on Cancer (IARC), global cancer cases are projected to rise by 77% by 2050, substantially increasing demand for high-resolution, multimodal imaging. Neuro & Spine imaging also forms a significant share due to increasing neurological disorders; the WHO reports that neurological conditions affect over 3 billion people globally, boosting demand for MRI and CT diagnostics.
Medical Imaging Market- Geographical Insights
Global medical imaging demand is strongly influenced by regional diagnostic capacity, healthcare infrastructure investments, and non-communicable disease prevalence. North America holds the largest value share, supported by very high utilization of CT and MRI: OECD data show the U.S. among the leading countries for MRI units and diagnostic exam volume per 1,000 population. Besides, Asia-Pacific is expected to grow fastest, driven by surging hospital construction, rising chronic disease burden, and capacity expansion in China, India, Japan, and Southeast Asia. Japan has one of the highest diagnostic-equipment densities in the region, with 55 MRI units per million population. Meanwhile, Europe, Latin America, and the Middle East & Africa are growing through continued hospital modernization, public health investments, and increasing adoption of point-of-care imaging.
U.S. Medical Imaging Market-Country Insights
The United States is a cornerstone of the global medical imaging market, with among the highest equipment density and utilization. According to OECD data, the U.S. had 37.99 MRI units per million people in 2021. In addition, OECD's Health at a Glance 2023 shows the U.S. among the top OECD countries with combined CT, MRI, and PET exam usage exceeding 360 exams per 1,000 population. High utilization, advanced reimbursement models, and well-funded hospital systems support uptake of high-end scanners, AI-enabled software, and recurring service models. OEMs and imaging companies benefit from a mature installed base and recurring upgrades for hardware, software, and maintenance.
Growing diagnostic demand, accelerated radiology workloads, and rapid modality modernization continue to intensify competition across the medical imaging ecosystem. Leading players include Siemens Healthineers, GE HealthCare, Philips, Canon Medical Systems, Fujifilm Healthcare, Hologic, Shimadzu Corporation, and Bracco Imaging. These companies focus on technology differentiation through advanced detector materials, low-dose imaging, and AI-powered workflow automation. Common strategies include expanding modality portfolios, enhancing interoperability, and strengthening after-sales service to secure long-term equipment lifecycles. Partnerships with hospitals, AI startups, and cloud-platform providers accelerate innovation, while targeted acquisitions and regional manufacturing investments improve market access, regulatory compliance, and competitive positioning.
In July 2025, GE HealthCare launched the Definium Pace Select ET, a floor-mounted digital X-ray system that uses AI to automate repetitive tasks, improve patient positioning accuracy, and reduce technologist strain - boosting throughput and consistency in high-volume imaging environments.
In March 2025, Clario acquired imaging provider NeuroRx to expand its capabilities in neuroimaging and data analytics. The acquisition will boost Clario's footprint in AI-driven imaging trials, enable more efficient brain scan data collection and harmonization, and strengthen its offering for neuro-degenerative and CNS clinical studies.